RT | January 18, 2022 A fourth dose of Pfizer’s coronavirus vaccine showed dwindling effectiveness against the Omicron variant, according to a trial conducted in Israel, with one of its lead researchers saying the immunization is simply “not good enough.” A study involving 154 medical staffers at Sheba Medical Center near Tel Aviv found that […]
Source